DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial ; volume:25 ; number:1 ; day:26 ; month:1 ; year:2024 ; pages:1-17 ; date:12.2024
Trials ; 25, Heft 1 (26.1.2024), 1-17, 12.2024
- Urheber
-
Nampota-Nkomba, Nginache
Nyirenda, Osward M.
Mallewa, Jane
Chimalizeni, Yamikani
Dzabala, Nettie
Fay, Michael P.
Gopalakrishnan, Mathangi
Laurens, Matthew B.
O’Brien, Nicole F.
Miller, Louis H.
Pierce, Susan K.
Riggle, Brittany A.
Postels, Douglas G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-023-07808-w
- URN
-
urn:nbn:de:101:1-2024040811191574260018
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nampota-Nkomba, Nginache
- Nyirenda, Osward M.
- Mallewa, Jane
- Chimalizeni, Yamikani
- Dzabala, Nettie
- Fay, Michael P.
- Gopalakrishnan, Mathangi
- Laurens, Matthew B.
- O’Brien, Nicole F.
- Miller, Louis H.
- Pierce, Susan K.
- Riggle, Brittany A.
- Postels, Douglas G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial
What does a modified-Fibonacci dose-escalation actually correspond to?
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemia
Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial
What does a modified-Fibonacci dose-escalation actually correspond to?
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemia
Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial
What does a modified-Fibonacci dose-escalation actually correspond to?
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemia